Phase 2 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderately to severely active ulcerative colitis (a condition causing inflammation of the large intestine)
- People who are currently taking certain approved medications for ulcerative colitis at a therapeutic dose may still be considered
Who may not be able to join:
- People with a very severe form of ulcerative colitis that affects a large portion of the colon
- People who have been diagnosed with Crohn's disease or indeterminate colitis (a type of bowel inflammation that is difficult to classify), or who have or have had a fistula (an abnormal tunnel-like connection in the body) that may suggest Crohn's disease
- People who have been diagnosed with microscopic colitis, ischemic colitis (reduced blood flow to the colon), or colitis caused by an infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of Participants Achieving Clinical Remission as Assessed by Modified Mayo Score (MMS) at Week 52
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.